Nitrosamines as nicotinic receptor ligands
- 19 March 2007
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 80 (24-25) , 2274-2280
- https://doi.org/10.1016/j.lfs.2007.03.006
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- NNK activates ERK1/2 and CREB/ATF‐1 via β‐1‐AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cellsInternational Journal of Cancer, 2006
- International lung cancer trends by histologic type: Male:Female differences diminishing and adenocarcinoma rates risingInternational Journal of Cancer, 2005
- Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFκB activation and cyclin D1 up-regulationToxicology and Applied Pharmacology, 2005
- Up‐regulation of Vascular Endothelial Growth Factor‐C by Nicotine in Cervical Cancer Cell LinesAmerican Journal of Reproductive Immunology, 2005
- Neuroendocrine lung carcinogenesis in hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas is promoted: implications for chemoprevention in smokersLung Cancer, 2004
- Prenatal nicotine increases pulmonary α7 nicotinic receptor expression and alters fetal lung development in monkeysJournal of Clinical Investigation, 1999
- The Biological Significance of Tobacco-SpecificN-Nitrosamines: Smoking and Adenocarcinoma of the LungCritical Reviews in Toxicology, 1996
- Oxygen sensing in airway chemoreceptorsNature, 1993
- Small cell lung cancer: Etiology, biology, clinical features, staging, and treatmentCurrent Problems in Cancer, 1993
- An animal model for neuroendocrine lung cancerCarcinogenesis: Integrative Cancer Research, 1988